WASHINGTON, Sept. 17, 2015 (GLOBE NEWSWIRE) -- Doug Peddicord, PhD, Executive Director of the Association of Clinical Research Organizations (ACRO), today issued the following statement regarding President Obama's nomination of Dr. Robert Califf to serve as the next Commissioner of the Food and Drug Administration:
"ACRO welcomes the nomination of Dr. Califf as FDA Commissioner. We have worked closely with Rob through the Clinical Trials Transformation Initiative and other collaborations and look forward to having a FDA Commissioner who understands and appreciates the critical role clinical research organizations play in today's drug development process. His extensive experience in clinical research and translational medicine will greatly benefit the agency and the American people as the concepts in 21st Century Cures are implemented."
The Association of Clinical Research Organizations (ACRO) represents companies that provide a variety of specialized services that support the development of new pharmaceuticals, biologics, and medical devices. The Association provides an active voice for the CRO industry globally. Through its member companies, ACRO helps improve the quality, efficiency and safety of biomedical research. ACRO member companies employ approximately 110,000 professionals worldwide and conduct research in 142 countries. For more information, please visit www.acrohealth.org. Twitter @acrohealth. YouTube @ACROHealthChannel. Facebook, RebelMouse.
CONTACT: John Lewis email@example.com 202.464.9340Source:Association of Clinical Research Organizations(ACRO)